scholarly article | Q13442814 |
P50 | author | Janet Daling | Q20807295 |
P2093 | author name string | C I Li | |
D J Uribe | |||
P2860 | cites work | Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome | Q21092905 |
Postmenopausal estrogen and progestin use in relation to breast cancer risk | Q34525017 | ||
Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma. | Q40497303 | ||
A comparison of the biological and clinical features of invasive lobular and ductal carcinomas of the breast | Q40522832 | ||
Experience with lobular carcinoma of the breast. Emphasis on recent aspects of management | Q41541827 | ||
Age distribution of histologic types of breast carcinoma | Q43952114 | ||
Relationship between long durations and different regimens of hormone therapy and risk of breast cancer | Q44489759 | ||
Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years. | Q44677780 | ||
Hormone receptor status of breast cancer in India: a study of 798 tumours | Q47255446 | ||
Trends in incidence rates of invasive lobular and ductal breast carcinoma | Q47403953 | ||
Risk of Mortality by Histologic Type of Breast Cancer Among Women Aged 50 to 79 Years | Q47444766 | ||
Misclassification bias related to definition of menopausal status in case-control studies of breast cancer | Q52860364 | ||
Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States) | Q57268418 | ||
Inflammatory Breast Carcinoma and Noninflammatory Locally Advanced Breast Carcinoma: Distinct Clinicopathologic Entities? | Q60148921 | ||
Infiltrating lobular carcinoma of the breast | Q70338114 | ||
Surveillance, epidemiology, and end results: incidence and mortality data, 1973-77 | Q70919678 | ||
Tumor biology of infiltrating lobular carcinoma. Implications for management | Q71779435 | ||
Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? | Q72359886 | ||
Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors | Q72825296 | ||
Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women | Q73911298 | ||
The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile | Q75344740 | ||
Hormone replacement therapy in relation to breast cancer | Q77651681 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | breast cancer | Q128581 |
P304 | page(s) | 1046-1052 | |
P577 | publication date | 2005-10-01 | |
P1433 | published in | British Journal of Cancer | Q326309 |
P1476 | title | Clinical characteristics of different histologic types of breast cancer | |
P478 | volume | 93 |
Q45401326 | A Low-Cost, Low-Skill Model for Efficient Breast Cancer Screening in Low Resource Rural Settings of a Developing Country |
Q63366126 | A component of lobular carcinoma in clinically lymph node-negative patients predicts for an increased likelihood of upstaging to pathologic stage III breast cancer |
Q50318351 | A locally advanced breast cancer with difficult differential diagnosis of carcinosarcoma and atypical medullary carcinoma, which had poor response to adriamycin- and taxane-based neoadjuvant chemotherapy: a case report. |
Q58834538 | A study of ductal versus non-ductal invasive breast carcinomas in older women: long-term clinical outcome and comparison with their younger counterparts |
Q38186556 | Aberrant DNA methylation of microRNA genes in human breast cancer - a critical appraisal |
Q34467216 | Absence of microsatellite instability in mucinous carcinomas of the breast. |
Q53599257 | Alcohol Intake and Risk of Breast Cancer by Histologic Subtype and Estrogen Receptor Status Among Women Aged 55 to 74 Years. |
Q34230233 | Alcohol and risk of breast cancer in postmenopausal women: an analysis of etiological heterogeneity by multiple tumor characteristics |
Q34132812 | Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study |
Q36021686 | Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype |
Q58604437 | Breast Cancer in Basra Oncology Center: A Clinico- Epidemiological Analysis |
Q92916943 | Breast Cancer: Current Perspectives on the Disease Status |
Q35370118 | Breast cancer - one term, many entities? |
Q37602561 | Breast cancer in systemic lupus erythematosus |
Q37551363 | Breast carcinoma--rare types: review of the literature |
Q92989260 | Cadmium Exposure and Risk of Breast Cancer by Histological and Tumor Receptor Subtype in White Caucasian Women: A Hospital-Based Case-Control Study |
Q48180862 | Characteristics and long-term survival of patients diagnosed with pure tubular carcinoma of the breast. |
Q89847095 | Characteristics of Special Type Breast Tumors in Our Center |
Q92890042 | Characterization of Kelch domain-containing protein 7B in breast tumours and breast cancer cell lines |
Q31140585 | Chemotherapy Significantly Improves Survival for Patients with T1c-T2N0M0 Medullary Breast Cancer: 3739 Cases From the National Cancer Data Base |
Q38431284 | Clinical management of breast cancer heterogeneity |
Q40135743 | Clinical role of HER2 gene amplification and chromosome 17: a study on 154 IHC-equivocal cases of invasive breast carcinoma patients. |
Q57815796 | Clinicopathologic characteristics and clinical outcomes of pure type and mixed type of tubular carcinoma of the breast: a single-institution cohort study |
Q36032521 | Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study |
Q44415353 | Clinicopathological characteristics and prognosis of mucinous breast carcinoma |
Q33680221 | Clinicopathological characteristics of mucinous carcinoma of the breast in Korea: comparison with invasive ductal carcinoma-not otherwise specified |
Q91692229 | Comparative Analysis of Outcomes and Clinicopathological Characteristics of Synchronous and Metachronous Contralateral Breast Cancer: A Study of the SEER Database |
Q36908141 | Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma |
Q37244058 | Comparison of clinicopathological characteristics of lymph node positive and lymph node negative breast cancer |
Q89529839 | Comparison of the Distribution Pattern of 21-Gene Recurrence Score between Mucinous Breast Cancer and Infiltrating Ductal Carcinoma in Chinese Population: A Retrospective Single-Center Study |
Q37484662 | Comparison of the characteristics of medullary breast carcinoma and invasive ductal carcinoma. |
Q90599833 | Correlation between apparent diffusion coefficient values in breast magnetic resonance imaging and prognostic factors of breast invasive ductal carcinoma |
Q35172218 | Cytotoxic activity of ten algae from the Persian Gulf and Oman Sea on human breast cancer cell lines; MDA-MB-231, MCF-7, and T-47D |
Q89686492 | DNA methylation landscape of triple-negative ductal carcinoma in situ (DCIS) progressing to the invasive stage in canine breast cancer |
Q37225635 | Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma: a population based study from SEER 18 database |
Q36415430 | Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer. |
Q64234735 | Differences in race, molecular and tumor characteristics among women diagnosed with invasive ductal and lobular breast carcinomas |
Q45059731 | Does primary breast cancer in older women (≥80 years) have unfavorable histological characteristics? |
Q93010229 | Early metabolic response of breast cancer to neoadjuvant endocrine therapy: comparison to morphological and pathological response |
Q90430465 | Effectivity of combined diffusion-weighted imaging and contrast-enhanced MRI in malignant and benign breast lesions |
Q33833475 | Emerging immunotherapeutics in adenocarcinomas: A focus on CAR-T cells |
Q57107109 | Epidemiological, Clinical, and Histopathological Features of Breast Cancer in Haiti |
Q36611606 | Established breast cancer risk factors by clinically important tumour characteristics |
Q48364519 | Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients |
Q37631744 | Expression of Lipid Metabolism-Related Proteins Differs between Invasive Lobular Carcinoma and Invasive Ductal Carcinoma. |
Q33898676 | Expression of autophagy related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma |
Q51609262 | Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma. |
Q84907028 | Expression of metalloproteases and their inhibitors in different histological types of breast cancer |
Q53687423 | Expression of p27 and c-Myc by immunohistochemistry in breast ductal cancers in African American women. |
Q35421375 | Expression of sarcosine metabolism-related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma. |
Q34733888 | Expression of the RNA helicase DDX3 and the hypoxia response in breast cancer |
Q53276495 | Expression patterns of stromal MMP-2 and tumoural MMP-2 and -9 are significant prognostic factors in invasive ductal carcinoma of the breast. |
Q57105820 | F-FDG PET/CT for Systemic Staging of Newly Diagnosed Breast Cancer in Men |
Q39122509 | FDG PET/CT Assesses the Risk of Femoral Pathological Fractures in Patients With Metastatic Breast Cancer |
Q43272689 | Fischer's score criteria correlating with histopathological prognostic factors in invasive breast cancer. |
Q34518541 | G protein-coupled estrogen receptor regulates mammary tumorigenesis and metastasis |
Q47558826 | Her-2 positive mucinous carcinoma breast cancer, case report |
Q41297799 | High excision repair cross-complementation group 1 expression is associated with favorable prognostic factors in breast cancer |
Q33584230 | Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: a register-based study in Norway |
Q57307176 | Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrences |
Q34616569 | Histological, molecular and functional subtypes of breast cancers |
Q34572280 | Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis |
Q35749359 | Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients |
Q38241276 | Illuminating breast cancer invasion: diverse roles for cell-cell interactions |
Q37300556 | Impact of social and clinical factors on diagnostic delay of breast cancer: A Cross-sectional Study. |
Q36128930 | Infiltrating lobular carcinoma of the breast presenting as gastrointestinal obstruction: a mini review |
Q35890623 | Inflammatory Breast Cancer: A Distinct Clinicopathological Entity Transcending Histological Distinction |
Q44536037 | Influence of uncommon histology on breast conservation therapy for breast cancer-biology dictates technique? |
Q56999072 | Integrated analysis of dysregulated lncRNA expression in breast cancer cell identified by RNA-seq study |
Q60935039 | Integration of Cancer Registry Data into the Text Information Extraction System: Leveraging the Structured Data Import Tool |
Q35743495 | Interrelationships Between Ki67, HER2/neu, p53, ER, and PR Status and Their Associations With Tumor Grade and Lymph Node Involvement in Breast Carcinoma Subtypes: Retrospective-Observational Analytical Study |
Q50227670 | Intratumoral estrogen production and actions in luminal A type invasive lobular and ductal carcinomas. |
Q54649194 | Invasive Lobular Breast Cancer: Does Grade Matter? |
Q42518349 | Invasive breast cancer: a significant correlation between histological types and molecular subgroups |
Q37209538 | Invasive ductal carcinoma of the breast with osteoclast-like giant cells and clear cell features: a case report of a novel finding and review of the literature |
Q37531363 | Invasive ductal carcinoma with lobular features: a comparison study to invasive ductal and invasive lobular carcinomas of the breast |
Q55396783 | Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism. |
Q40061357 | Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma |
Q34179808 | Late age at first full term birth is strongly associated with lobular breast cancer |
Q35170028 | Lobular breast cancer: incidence and genetic and non-genetic risk factors |
Q89941347 | Lobular breast carcinoma metastatic to the endometrium in a patient under tamoxifen therapy: A case report |
Q92646038 | Low nuclear zinc finger and BTB domain containing 7A expression is an independent prognostic factor for recurrence-free survival in invasive ductal carcinoma of the breast |
Q33307561 | MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature |
Q40171298 | Mammographic and ultrasound features of invasive lobular carcinoma of the breast |
Q36251444 | Management of unusual histological types of breast cancer |
Q90476180 | Medullary Breast Carcinoma and Invasive Ductal Carcinoma: A Review Study |
Q57107113 | Metastatic Breast Cancer Presenting As Orbital Mass: A Case Report With Literature Review |
Q59465999 | Microfluidics: Rapid Diagnosis for Breast Cancer |
Q34086486 | Microtubule-associated protein Mdp3 promotes breast cancer growth and metastasis |
Q90286878 | Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade |
Q41605699 | Mixed invasive ductal and lobular carcinoma has distinct clinical features and predicts worse prognosis when stratified by estrogen receptor status |
Q37708047 | Molecular Classification of Lobular Carcinoma of the Breast |
Q33799226 | Mucinous breast cancer - clinical characteristics and treatment results in patients treated at the Oncology Centre in Kraków between 1952 and 2002 |
Q51549423 | Multifocal, multicentric and contralateral breast cancers: breast MR imaging in the preoperative evaluation of patients with newly diagnosed breast cancer. |
Q42450636 | Mutations in EGFR, BRAF and RAS are rare in triple-negative and basal-like breast cancers from Caucasian women |
Q36422503 | New primary ipsilateral metachronous breast tumor: a case report |
Q55025978 | Omission of Postoperative Radiotherapy in Women Aged 65 Years or Older With Tubular Carcinoma of the Breast After Breast-Conserving Surgery. |
Q92431904 | PREDICTIVE CIRCULATING MARKERS FOR ANTHRACYCLINE CHEMOTHERAPY IN NON-METASTATIC BREAST CANCER |
Q26769704 | Papillary carcinoma of breast: Minireview |
Q37222882 | Pattern of Breast Cancer Distribution in Ghana: A Survey to Enhance Early Detection, Diagnosis, and Treatment. |
Q38101747 | Pitfalls in outcome prediction of breast cancer. |
Q90476371 | Presence of circulating tumor cells is associated with metabolic-related variables in postoperative patients with early-stage breast cancer |
Q38319569 | Primary breast cancer in the elderly: a systematic literature review on histological type and clinical outcome. |
Q35840060 | Prognostic Role of Adjuvant Chemotherapy in Node-Negative (N0), Triple-Negative (TN), Medullary Breast Cancer (MBC) in the Korean Population |
Q101403266 | Prognostic and predictive parameters in breast pathology: a pathologist's primer |
Q40471089 | Prospective Clinical Trial of 18F-Fluciclovine PET/CT for Determining the Response to Neoadjuvant Therapy in Invasive Ductal and Invasive Lobular Breast Cancers. |
Q91586076 | Quantitative assessment of Ki67 expression in correlation with various breast cancer characteristics and survival rate; cross sectional study |
Q47355574 | Rapid virtual hematoxylin and eosin histology of breast tissue specimens using a compact fluorescence nonlinear microscope. |
Q64045407 | Rare breast neoplasms: is there any peculiar feature on magnetic resonance mammography? |
Q43693997 | Re-excision rates of invasive ductal carcinoma with lobular features compared with invasive ductal carcinomas and invasive lobular carcinomas of the breast |
Q33693138 | Recent changes in breast cancer incidence and risk factor prevalence in San Francisco Bay area and California women: 1988 to 2004. |
Q33876067 | Relationship among mammographic findings with histopathologic type of breast cancer and human epidermal growth factor receptor 2 (HER2) in young women |
Q35013079 | Reproductive factors and histologic subtype in relation to mortality after a breast cancer diagnosis |
Q37135273 | Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis |
Q37120162 | Reproductive factors, age at maximum height, and risk of three histologic types of breast cancer |
Q48328328 | Reproductive risk factor associations with lobular and ductal carcinoma in the Carolina Breast Cancer Study. |
Q89966634 | Response of metastatic mouse invasive lobular carcinoma to mTOR inhibition is partly mediated by the adaptive immune system |
Q34613642 | Risk factors for ductal and lobular breast cancer: results from the nurses' health study |
Q33903091 | Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population |
Q37055548 | Risk factors for specific histopathological types of postmenopausal breast cancer in the NIH-AARP Diet and Health Study |
Q35750765 | Risk factors for uncommon histologic subtypes of breast cancer using centralized pathology review in the Breast Cancer Family Registry |
Q84563118 | Risk of mortality by histologic type of breast cancer in the United States |
Q88723009 | Sentinel Lymph Node Metastasis in Invasive Lobular Carcinoma of the Breast |
Q91713420 | Sphingosine Kinase 1 in Breast Cancer-A New Molecular Marker and a Therapy Target |
Q90072180 | Structured light imaging for breast-conserving surgery, part I: optical scatter and color analysis |
Q38834039 | Survival differences of CIMP subtypes integrated with CNA information in human breast cancer |
Q47552011 | Synchronous Uterine Metastases from Breast Cancer: Case Study and Literature Review |
Q38944944 | The CpG island methylator phenotype in breast cancer is associated with the lobular subtype |
Q60951040 | The Distribution and Outcomes of the 21-Gene Recurrence Score in T1-T2N0 Estrogen Receptor-Positive Breast Cancer With Different Histologic Subtypes |
Q99629722 | The Impact of Preoperative Breast Magnetic Resonance Imaging on Surgical Management in Symptomatic Patients With Invasive Lobular Carcinoma |
Q92757846 | The Role of ZNF143 in Breast Cancer Cell Survival Through the NAD(P)H Quinone Dehydrogenase 1⁻p53⁻Beclin1 Axis Under Metabolic Stress |
Q57472254 | The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer |
Q51747356 | The combined association of modifiable risk factors with breast cancer risk in the Women's Health Initiative. |
Q36810356 | The heterogeneity of epithelial ovarian cancers: reconciling old and new paradigms |
Q33761874 | The invasive lobular carcinoma as a prototype luminal A breast cancer: a retrospective cohort study |
Q39175548 | The molecular basis of breast cancer pathological phenotypes |
Q39703687 | Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis. |
Q38997433 | Treatment choices for patients with invasive lobular breast cancer: a doctor survey |
Q55518016 | Trimodal distribution of arylamine N-acetyltransferase 1 mRNA in breast cancer tumors: association with overall survival and drug resistance. |
Q33852544 | Tumor Lysis Syndrome in Solid Tumors: An up to Date Review of the Literature |
Q36411711 | Tumor characteristics and the clinical outcome of invasive lobular carcinoma compared to infiltrating ductal carcinoma in a Chinese population |
Q40382207 | Uncovering Professional Attitudes Toward Treatment of Rare Carcinomas of the Breast: An International Practice e-Survey Involving 32 Countries |
Q30454418 | Unusual aggressive breast cancer: metastatic malignant phyllodes tumor |
Q33808614 | Unusual primary breast cancer - malignant peripheral nerve sheath tumor: a case report and review of the literature |
Q36593545 | Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer |
Q47609280 | Zinc finger protein 143 expression is closely related to tumor malignancy via regulating cell motility in breast cancer |
Q91831588 | [Diagnostic and therapeutic features of invasive lobular carcinoma of the breast: a study of 30 cases] |
Q57129131 | [Lobular neoplasms and invasive lobular breast cancer] |
Search more.